Aurobindo Pharma shares rise 2% on USFDA nod for nasal spray
The pharma company has received approval to manufacture and market Mometasone Furoate Monohydrate Nasal Spray 50 mcg, which will be launched in Q1 FY25.
us fda
March 2024
December 2023
August 2023
June 2023
May 2023
March 2023
December 2022
From ₹397 to ₹1,081: This largecap pharma stock surges 170% in 10 months
The homegrown pharma company has outperformed the BSE Sensex and Healthcare index in terms of returns in the last one year.
U.S. FDA issues warning letter to Intas Pharma over manufacturing lapses
The U.S. FDA says the company's quality control unit failed to ensure its drug products meet specifications for "identity, strength, quality, and purity"
Lupin shares rise 2% on launching heart drug in Canada
The pharma major’s subsidiary has launched Propranolol LA capsules, 60 mg, 80 mg, 120 mg, and 160 mg, in Canada.
US FDA flags ‘significant violations’ of CGMP norms at Gujarat-based Intas Pharma
The FDA asks the company to "correct any violations promptly", failing which the global agency may withhold approval of new applications or supplements listing
Lupin hits 52-week high on US FDA nod for respiratory drug
The scrip opened a gap-up at ₹834.95 on Wednesday against the closing price of the previous session at ₹829.65.
Cough syrup row: Sample testing at designated labs now must for exporters
From June 1, 2023, cough syrup will be permitted to be exported only after testing and production of certificate issued by govt labs
US FDA halts Sun Pharma’s trial on dermatological drugs; stock down
The federal agency has put on hold the trial of 12 mg of Deuruxolitinib clinical trial owing to a potential pulmonary embolism.
Lupin shares dip 4% on US FDA observations for Pithampur unit
The U.S. drug regulator has issued Form 483 with ten observations for Lupin’s Pithampur unit-2 manufacturing facility.
Lupin recalls blood pressure tablets in U.S.; stock up 3%
Lupin Pharmaceuticals Inc., the U.S. arm of the drug major, is voluntarily recalling four lots of Quinapril Tablets due to the presence of nitrosamine impurity.
